Rheumatoid Arthritis Trial, Recruiting NCT05966519 Sponsor: Zimmer Biomet Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT05966519
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 20 years or older
  • People whose bones have finished growing and reached full maturity
  • People for whom a decision to have a total knee replacement using the ROSA Knee System has already been made independently, before being considered for the study
  • People who are able and willing to attend all follow-up appointments as outlined in the study plan
  • People who have gone through the informed consent process and are willing to sign the required consent form approved by an ethics committee

Who may not be able to join:

  • People who have serious bone defects that require metal additions, synthetic bone, or donor bone material
  • People who have an active infection, blood poisoning, or a bone infection at the affected joint
  • People who have poor blood flow, muscle loss, or nerve and muscle conditions at the area where the implant would be placed, which could affect the outcome of surgery
  • People who have another condition that is likely to affect how well the implant works or lasts
  • People who are known to be pregnant
  • People who are prisoners, or who have a known issue with alcohol or drug misuse, or who are not able to understand what taking part in the study involves
  • People who are known to have a sensitivity or allergy to any of the materials used in the implant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yasuharu Nakashima, Kyushu University

Phone: +81-3-6402-6600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zimmer Biomet
Registry
ClinicalTrials.gov
Start date
5 January 2024
Est. completion
1 January 2027

Where this trial is recruiting

🇯🇵 Japan

Primary endpoints

The mean absolute difference between X-Atlas image based pre-op plan & intra-op final plan

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov